TheFiscalFinder
Contractors / Sanofi Vaccines US Inc.

Sanofi Vaccines US Inc.

prime recipient of federal awards · Subsidiary of Sanofi S.A. · France ≈ inferred · UEI NCXBGGQ8YTU9 ✓ from source
$1.1B
obligated · FY2025
5
funding agencies
98%
from Health and Hum…
36%
single-source
5
states
6%
in Pennsylvania
6
industries

≈ computedSingle-source: 36% of this recipient’s $72.7M in federal contracts was awarded without competition (FPDS extent-competed codes); the rest was competed or unclassified. A high share often reflects sole-source or specialized work, not wrongdoing.

Obligations by year

≈ computed
$974.8M
FY20
$741.2M
FY21
$707.4M
FY22
$579.6M
FY23
$1.6B
FY24
$1.1B
FY25
17%
since FY20

Where this money comes from

✓ from source
FUNDING AGENCIES
SANOFI VACCINES US INC.
HHS
$1.1B
4 other agencies
$0B
Sanofi Vaccines US Inc.
$1.1B
FY2025 obligated
band width = obligations · FY2025 · source: USASpending.gov

Biggest awards (total value)

awarded 2011$640M
awarded 2017$477.2M
awarded 2015$201.5M
awarded 2016$136.4M

Total value over each award’s life, for awards active in FY2025: a decades-long contract can exceed one year’s obligations above.

Where the work lands

Pennsylvania✓ from source$72.8M
Oklahoma✓ from source$72.4K
District Of Columbia✓ from source$38.8K
New Jersey✓ from source$8.8K

Competitors

Mckesson Corporation≈ computed$11.9B
Merck Sharp & Dohme LLC≈ computed$2.9B
Glaxosmithkline, LLC≈ computed$958.8M
Pfizer Inc≈ computed$700.6M
Alvogen, Inc.≈ computed$227.7M
Bavarian Nordic A/S≈ computed$143.6M

computed from shared NAICS, not a stated rivalry.

Corporate family

Single registration: no combined family.

🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.